BioMime Sirolimus-Eluting Coronary Stent System

The BioMime DES, with its Cobalt-Chromium platform and Sirolimus drug elution, is backed by extensive global clinical data demonstrating superior lesion coverage and reduced late lumen loss, leading to improved clinical outcomes and precise drug delivery to the targeted site.

The Cobalt-Chromium platform of the BioMime DES offers enhanced biocompatibility, reduced neo-intimal hyperplasia, and optimal radial strength. This, coupled with Sirolimus, minimizes adverse reactions and promotes faster endothelialization compared to alternative polymers.

The BioMime DES provides excellent deliverability and lesion crossability due to its low crossing profile and flexible design. This enables easier navigation through complex anatomies, reducing procedural time and enhancing the overall surgical experience.

This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.

Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the BioMime Sirolimus-Eluting Coronary Stent System, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.

The BioMime Sirolimus-Eluting Coronary Stent System is constructed using Cobalt-Chromium, ensuring high biocompatibility and durability.